Items where authors include "Fishwick, C.W.G."

Article

Gill, J.H., Sellars, J.D., Waddell, P.G. et al. (3 more authors) (2025) Development of novel benzamide class I selective lysine deacetylase inhibitors as potent anticancer agents. Journal of Enzyme Inhibition and Medicinal Chemistry, 40 (1). 2520612. ISSN 1475-6366

Matos, R.G., Simmons, K.J. orcid.org/0000-0003-4846-9097, Fishwick, C.W.G. et al. (2 more authors) (2024) Identification of Ribonuclease Inhibitors for the Control of Pathogenic Bacteria. International Journal of Molecular Sciences, 25 (15). 8048. ISSN 1661-6596

Turvey, S., Muench, S.P. orcid.org/0000-0001-6869-4414, Issad, T. et al. (3 more authors) (2024) Using site-directed mutagenesis to further the understanding of insulin receptor-insulin like growth factor-1 receptor heterodimer structure. Growth Hormone & IGF Research, 77. 101607. ISSN 1096-6374

Lykins, J., Moschitto, M.J., Zhou, Y. et al. (26 more authors) (2024) From TgO/GABA-AT, GABA, and T-263 Mutant to Conception of Toxoplasma. iScience, 27 (1). 108477. ISSN 2589-0042

Bedingfield, P.T.P., Cowen, D., Acklam, P. et al. (5 more authors) (2012) Factors Influencing the Specificity of Inhibitor Binding to the Human and Malaria Parasite Dihydroorotate Dehydrogenases. Journal of Medicinal Chemistry, 55 (12). pp. 5841-5850. ISSN 0022-2623

Cowen, D., Bedingfield, P., McConkey, G.A. orcid.org/0000-0001-6529-794X et al. (2 more authors) (2010) A study of the effects of substituents on the selectivity of the binding of N-arylaminomethylene malonate inhibitors to DHODH. Bioorganic & Medicinal Chemistry Letters, 20 (3). pp. 1284-1287. ISSN 0960-894X

Grigg, R., McCaffrey, S., Sridharan, V. et al. (5 more authors) (2006) Enantioselective synthesis of non-proteinogenic 2-arylallyl-α-amino acids via Pd/In catalytic cascades. Tetrahedron, 62 (52). pp. 12159-12171. ISSN 0040-4020